Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: been reading the board a while

The original patent application had been submitted as one patent. The USPTO determined that it was actually seven different inventions. I guess you could say that TPL countered by licensing it as a portfolio of patents. They don't market it individually. I am certain that that is part of the contention of infringers.

From the Optoma License announcement PR :

"CARLSBAD, Calif., Feb. 9 /PRNewswire-FirstCall/ -- Patriot Scientific Corporation (OTC Bulletin Board: PTSC) announced today Optoma Technology, Inc. has purchased a Moore Microprocessor Patentâ„¢ (MMP) Portfolio license from The TPL Group."

"The MMP Portfolio includes seven U.S. patents as well as their European and Japanese counterparts. It is widely recognized that the MMP Portfolio protects fundamental technology used in microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors and system-on-chip (SoC) devices"

Share
New Message
Please login to post a reply